PROMETHEUS SAFE & SECURE LTD

1. Industry Classification

Prometheus Safe & Secure Ltd is registered under SIC 52290 — Other transportation support activities — which aligns with its operating reality as a non-emergency patient transport (NEPTS) provider. The strategic report describes the principal activity as healthcare services and patient transport services, while the directors’ report explicitly identifies provision of patient transport services to NHS Trusts and Emergency Services.

The company therefore sits at the intersection of two sectors: healthcare support services and demand-responsive passenger transport. This is a regulated niche within the wider private ambulance and patient transport market, often classified under transport support but economically driven by NHS commissioning, CQC oversight, and hospital discharge pathways.

2. Relative Performance

The available financial history shows a company growing strongly before a change in control:

• FY2021 (year to March 2021): turnover £5.53m, net assets £4.03m, cash £0.56m.
• FY2022 (year to March 2022): turnover £7.16m, up 29.5% year-on-year, with net assets of £5.75m and cash of £1.28m.
• Six-month period to September 2022: turnover of £5.04m — annualised at roughly £10.1m — suggesting continued acceleration. Net assets reached £6.43m and cash improved to £1.77m.

This is a well-capitalised balance sheet for the NEPTS sector. Total assets of £8.41m against total liabilities of £2.32m imply a robust equity ratio of around 76%, significantly stronger than many transport operators, where margin compression and fleet financing often weaken the balance sheet. The company also exited the pre-acquisition period with strong liquidity, which is notable in a sector where NHS payment cycles can create working capital strain.

The shortened accounting period was explicitly introduced because the company was acquired by RCI Group in December 2022, bringing its year end in line with the new parent. That means direct year-on-year comparisons across 2022/2023 are distorted, but the underlying trading narrative — organic growth, strong cash conversion, and disciplined working capital management — is consistent.

3. Sector Trends Impact

The UK NEPTS market is shaped by several structural and cyclical pressures:

• Elective care recovery and demographic demand: An ageing population, growing waiting lists, and increased hospital discharge activity all support demand for patient transport.
• ICB commissioning and NHS Standard Contract: Services are increasingly commissioned through Integrated Care Boards, with longer-term contracts but periodic retendering. Price pressure is continuous.
• Labour and fuel cost inflation: Driver shortages, National Living Wage increases, fuel volatility, and higher vehicle insurance costs have squeezed margins across the sector.
• Fleet decarbonisation: NHS Net Zero commitments are pushing providers toward electric or low-emission vehicles, requiring significant capital investment that can disadvantage smaller operators.
• Regulatory compliance: CQC registration and inspection, alongside NHS contract compliance, create a high operational bar.

Prometheus appears well positioned to absorb these pressures: its cash position supports fleet renewal, its long-term NHS relationships reduce contract churn risk, and its acquisition by RCI Group provides additional financial backing and group-level infrastructure.

4. Competitive Positioning

Within the NEPTS sector, Prometheus is best described as a niche, mid-market provider with regional strength, not a national market leader. The market includes large private groups, regional operators, and charitable/community transport bodies. Compared with national-scale competitors, Prometheus’s turnover is modest, but its profitability and balance sheet strength are above typical sector norms.

Key competitive strengths:

• Strong organic growth and a record of retaining NHS relationships.
• High liquidity and low leverage, allowing investment in fleet and infrastructure.
• Post-acquisition scale and governance through RCI Group, improving access to frameworks and cross-selling opportunities.
• Disciplined working capital management, reflected in the cash build-up over consecutive periods.

Primary vulnerabilities:

• Concentration on public-sector commissioning, leaving revenue exposed to NHS budget cycles and retendering outcomes.
• Regional and relationship-driven revenue base, meaning contract losses would have outsized impact.
• Limited diversification beyond patient transport, unlike diversified facilities management competitors.

Overall, Prometheus Safe & Secure Ltd is a credible, financially sound operator in a fragmented UK patient transport market. It is not a dominant national player, but it has demonstrated above-average financial resilience, and its integration into RCI Group positions it as a consolidation-minded regional leader rather than a passive contract taker.